恩替卡韦用于失代偿期乙肝肝硬化：前景愈发光明。 - Suppr

Suppr

超能文献

Entecavir in decompensated HBV cirrhosis: the future is looking brighter.

作者信息

Fontana Robert J

出版信息

J Hepatol. 2010 Feb;52(2):147-9. doi: 10.1016/j.jhep.2009.10.025. Epub 2009 Dec 16.

DOI:10.1016/j.jhep.2009.10.025

PMID:20006400

Abstract

摘要

相似文献

Entecavir in decompensated HBV cirrhosis: the future is looking brighter.恩替卡韦用于失代偿期乙肝肝硬化：前景愈发光明。

J Hepatol. 2010 Feb;52(2):147-9. doi: 10.1016/j.jhep.2009.10.025. Epub 2009 Dec 16.

[Antiviral effects of entecavir in patients with hepatitis B virus-related cirrhosis].恩替卡韦对乙型肝炎病毒相关性肝硬化患者的抗病毒作用

Zhonghua Gan Zang Bing Za Zhi. 2010 Feb;18(2):109-12. doi: 10.3760/cma.j.issn.1007-3418.2010.02.008.

Entecavir for the treatment of patients with hepatitis B virus-related decompensated cirrhosis.恩替卡韦治疗乙型肝炎病毒相关失代偿期肝硬化患者。

Expert Opin Pharmacother. 2013 Jul;14(10):1363-9. doi: 10.1517/14656566.2013.786701. Epub 2013 Apr 4.

Treatment of HBV-related cirrhosis.乙肝相关肝硬化的治疗

Expert Rev Anti Infect Ther. 2009 Jun;7(5):527-35. doi: 10.1586/eri.09.28.

Comparison of the efficacies of lamivudine versus entecavir in patients with hepatitis B virus-related decompensated cirrhosis.拉米夫定与恩替卡韦治疗乙型肝炎病毒相关失代偿期肝硬化患者的疗效比较。

Liver Int. 2012 Apr;32(4):656-64. doi: 10.1111/j.1478-3231.2011.02676.x. Epub 2011 Nov 17.

Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy.乙型肝炎病毒相关失代偿期肝硬化：抗病毒治疗的获益。

J Hepatol. 2012 Aug;57(2):442-50. doi: 10.1016/j.jhep.2012.02.033. Epub 2012 Apr 12.

[Emphasis on the antiviral therapy for decompensated hepatitis B-related cirrhosis].[重视失代偿期乙型肝炎相关肝硬化的抗病毒治疗]

Zhonghua Yi Xue Za Zhi. 2010 Jun 15;90(23):1585-6.

Efficacy of entecavir in treatment-naïve patients with hepatitis B virus-related decompensated cirrhosis.恩替卡韦治疗乙型肝炎病毒相关失代偿期肝硬化患者的疗效。

J Hepatol. 2010 Feb;52(2):176-82. doi: 10.1016/j.jhep.2009.11.007. Epub 2009 Dec 16.

Efficacy and safety of entecavir in patients with chronic hepatitis B and advanced hepatic fibrosis or cirrhosis.恩替卡韦治疗慢性乙型肝炎合并晚期肝纤维化或肝硬化患者的疗效与安全性。

Am J Gastroenterol. 2008 Nov;103(11):2776-83. doi: 10.1111/j.1572-0241.2008.02086.x. Epub 2008 Aug 21.

[Long-term entecavir efficacy retention in the treatment of chronic hepatitis B with an outcome to hepatic cirrhosis caused by its resistant virus strain].[恩替卡韦长期治疗慢性乙型肝炎对其耐药病毒株所致肝硬化结局的疗效维持情况]

Ter Arkh. 2012;84(11):61-3.

引用本文的文献

Management of chronic hepatitis B before and after liver transplantation.肝移植前后慢性乙型肝炎的管理

Frontline Gastroenterol. 2018 Jan;9(1):79-84. doi: 10.1136/flgastro-2016-100768. Epub 2017 Feb 14.

Prevention of hepatitis B virus-associated liver diseases by antiviral therapy.通过抗病毒治疗预防乙型肝炎病毒相关肝病

Hepatol Int. 2016 Jul;10(4):574-93. doi: 10.1007/s12072-016-9720-y. Epub 2016 Mar 29.

Lactic Acidosis during Entecavir Antiviral Treatment in a Patient with Hepatitis B Virus-related Decompensated Cirrhosis.乙型肝炎病毒相关性失代偿期肝硬化患者恩替卡韦抗病毒治疗期间的乳酸酸中毒

West Indian Med J. 2015 Mar;64(2):165-6. doi: 10.7727/wimj.2013.198. Epub 2015 Jan 27.

Entecavir: a review of its use in the treatment of chronic hepatitis B in patients with decompensated liver disease.恩替卡韦：治疗肝功能失代偿的慢性乙型肝炎患者的综述。

Drugs. 2011 Dec 24;71(18):2511-29. doi: 10.2165/11208510-000000000-00000.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验